Asadov(C),Shirinova(A),Alimirzoyeva(Z),Has... Cureus 2026-02-00

...ELN guidelines, appropriate regulatory frameworks, and patient-centered implementation strategies. Under these condition...

Barbhuiyan(S),Hazarika(M),Iqbal(A),Kakunje... Ecancermedicalscience None

...ELN) 2017 risk stratification, 52% of patients were categorized as favourable risk, 18% as intermediate risk and 28% as ...

Wang(L),Li(M),Xi(Y) Blood Lymphat Cancer None

...ELN) 2022 genetic risk stratification system. Expression levels of key genes were analyzed in GSE114868 and validated in...

Peng(Y),Demidchik(V),Li(Y),Zhou(D),Lin(Y),... Fitoterapia 2026-04-00

...ELNs (N-ELNs) via ultracentrifugation. Loganin, andrographolide, and asiatic acid were detected in N-ELNs using the HPLC...

Chang(YS),Lee(YW),Liu(CY),Othman(J),Eckard... Haematologica 2026-02-26

...ELN-2022) guidelines, except in the presence of FLT3-internal tandem duplication or adverse-risk cytogenetics. However, ...

Wang(Y),Fujikata(Y),Wong(L),Muramatsu(Y),M... Ultramicroscopy 2026-05-00

...ELNES) and X-ray Absorption Near Edge Structures (XANES), is a vital tool for materials characterization. However, its f...

Wolf(S),Zeltner(N),Henze(N),Enssle(JC),Kem... Infection 2026-08-00

...ELN 2022 genetic risk, sex, ECOG performance status, and allogeneic stem cell transplantation. Healthcare-exposure varia...

Kabelis(P),Rzeszutko-Bełzowska(A),Leońska-... J Appl Genet 2026-05-29

...ELN (rs2071307), FBN2 (rs331079), MMP1 (rs1799750), MMP10 (rs486055), and MMP12 (rs2276109) polymorphisms, either indivi...

Capria(S),Minotti(C),Breccia(M),Bisegna(ML... Hematol Rep 2026-08-12

...ELN 2017. Primary endpoints were overall survival (OS) and disease-free survival (DFS). Results: The cohort included 22 ...

Jiang(Q),Ding(Z),Li(S),Mo(X),Zhang(X),Huan... Biomaterials 2026-08-20

...ELN, COL9A2, and COL11A2, ultimately restoring cartilage structure and function. Rather than relying on a static therape...